Concepedia

Angelika Jahreis

AJ

Statistics

Publications

36

Citations

5.8K

H-Index

28

Active since

1992

Affiliations

University of Michigan(Current)

Amgen (United States)

Roche (United Kingdom)

Université Paris Cité

University of California, Los Angeles

Angelika Jahreis is an author at University of Michigan specializing in medicine, pharmacotherapy, and rheumatology.

Publications per year

1992–2021

36

Publications

36

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial

Stephen K. Tyring, Alice B. Gottlieb, Kim Papp et al. · The Lancet · 2005 · 1.1K citations

, , +6

Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial

Dinesh Khanna, Christopher P. Denton, Angelika Jahreis et al. · The Lancet · 2016 · 669 citations · Full text

, , +5

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst et al. · The Lancet Respiratory Medicine · 2020 · 652 citations · Full text

, , +4

Etanercept Treatment for Children and Adolescents with Plaque Psoriasis

Amy S. Paller, Elaine C. Siegfried, Richard G. Langley et al. · New England Journal of Medicine · 2008 · 388 citations · Full text

, , +9

Integrated safety in tocilizumab clinical trials

Michael Schiff, Joel M. Kremer, Angelika Jahreis et al. · Arthritis Research & Therapy · 2011 · 373 citations · Full text

, , +17

1–5 of 36